Silberman David 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Apr 20, 2023
Insider Transaction Report
Form 4
Silberman David
Chief Financial Officer
Transactions
- Award
Common Stock
2023-04-17+97,500→ 205,500 total
Footnotes (1)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 8,125 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.